Laying the foundation

Today, we offer a comprehensive range of analytical and advisory services to clients comprising the identification, development, validation, analysis and interpretation of biomarker and bioanalytical readouts in translational and clinical research.
Synexa was founded in 2003, an early pioneer in the emerging field of biomarker science. Growing steadily since then, the company has established its position as a leading expert in the field of biomarker and bioanalytical science.
The company has established its position as leading experts in the field of immunology.
Synexa is a privately-held company, backed by Gilde Healthcare, a specialized European healthcare investor. Synexa is led by a growing team of experienced scientists and business people, with over 70 scientists at its three laboratory locations.

To a better world

Synexa Life Sciences’ guiding principles reflect in our collaborative approach to providing customized, multi-faceted and flexible solutions to a client’s specific needs. We pride ourselves in identifying, implementing, and integrating optimum analytical and data insight methodologies, to contribute to the furtherment of scientific knowledge. This translates to better management and treatment of health conditions, ultimately, shaping a better world.

Through global scientific excellence


Continents we currently work in (all except Antarctica)


Types of matrices analysed


Highest number of reportable flow cytometry parameters in one study


No. of labs serviced by LymphoSure


Cumulative years of scientific experience

200 000+

Cytokine assays run to date